Glioma Prognostic Panel Test sale cost 3740 AED
Chronic Lymphocytic Leukemia CLL Prognostic Panel Test sale cost 4210 AED Chronic Lymphocytic Leukemia CLL Prognostic Panel Test Cost 4,680 د.إ Original price was: 4,680 د.إ.4,210 د.إCurrent price is: 4,210 د.إ.
Cancer Targeted Gene Panel Colon Colorectal Test sale cost 2970 AED Cancer Targeted Gene Panel Colon Colorectal Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
Sale!

Glioma Prognostic Panel Test Cost

Original price was: 4,160 د.إ.Current price is: 3,740 د.إ.

-10%

The Glioma Prognostic Panel Test is a cutting-edge diagnostic tool designed to provide vital information about gliomas, which are a type of tumor that occurs in the brain and spinal cord. By analyzing specific genetic markers within the tumor’s DNA, this test can offer insights into the tumor’s type, aggressiveness, and potential response to various treatments. This information is crucial for tailoring the most effective treatment plan for each individual patient, potentially improving outcomes and survival rates.

The test cost is set at 3740 AED and is available at DNA Labs UAE, a leading facility in genetic testing and analysis. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic diagnostics, ensuring that patients receive accurate and reliable results. By opting for the Glioma Prognostic Panel Test at DNA Labs UAE, patients and their healthcare providers can make informed decisions regarding the management of gliomas, based on a comprehensive understanding of the tumor’s genetic profile.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GLIOMA PROGNOSTIC PANEL Test

Test Cost: AED 3740.0

Symptoms, Diagnosis, and Referring Details

Test Name: GLIOMA PROGNOSTIC PANEL Test

Components: IDH1, IDH2, MGMT

Price: 3740.0 AED

Sample Condition: Submit formalin fixed paraffin embedded (FFPE) tissue block. Ship at room temperature. Block should have at least 5% tumor tissue.

Report Delivery: Sample should be sent by 11 am; Report will be delivered within 15 working days

Method: PCR, Next Generation Sequencing

Test Type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: No special preparation required

Test Details

The GLIOMA PROGNOSTIC PANEL test is a diagnostic tool used to assess the prognosis and predict the outcomes of patients with glioma, a type of brain tumor. This panel utilizes molecular profiling techniques to analyze specific genetic and molecular markers associated with glioma progression and response to treatment.

The test examines the expression levels of various genes and proteins that are known to play a role in glioma development and progression. By analyzing these markers, the GLIOMA PROGNOSTIC PANEL can provide valuable information about the aggressiveness of the tumor, the likelihood of recurrence, and the potential response to specific treatments.

The results of the GLIOMA PROGNOSTIC PANEL test can help guide treatment decisions, allowing healthcare providers to develop personalized treatment plans tailored to each patient’s specific needs. Additionally, this test can provide patients with a better understanding of their prognosis and help them make informed decisions about their healthcare.

It is important to note that the GLIOMA PROGNOSTIC PANEL test is just one tool used in the management of glioma, and its results should be interpreted in conjunction with other clinical and diagnostic information. The test should be ordered and interpreted by qualified healthcare professionals who are experienced in the management of glioma.

Test Name GLIOMA PROGNOSTIC PANEL Test
Components *IDH1*IDH2*MGMT
Price 3740.0 AED
Sample Condition Submit formalin fixed paraffin embedded (FFPE) tissue block.Ship at room temperature. Block should have atleast 5% tumor tissue.
Report Delivery Sample Sat by 11 am; Report 15 Workingdays
Method PCR, Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The GLIOMA PROGNOSTIC PANEL test is a diagnostic tool used to assess the prognosis and predict the outcomes of patients with glioma, a type of brain tumor. This panel utilizes molecular profiling techniques to analyze specific genetic and molecular markers associated with glioma progression and response to treatment.

The test examines the expression levels of various genes and proteins that are known to play a role in glioma development and progression. By analyzing these markers, the GLIOMA PROGNOSTIC PANEL can provide valuable information about the aggressiveness of the tumor, the likelihood of recurrence, and the potential response to specific treatments.

The results of the GLIOMA PROGNOSTIC PANEL test can help guide treatment decisions, allowing healthcare providers to develop personalized treatment plans tailored to each patient’s specific needs. Additionally, this test can provide patients with a better understanding of their prognosis and help them make informed decisions about their healthcare.

It is important to note that the GLIOMA PROGNOSTIC PANEL test is just one tool used in the management of glioma, and its results should be interpreted in conjunction with other clinical and diagnostic information. The test should be ordered and interpreted by qualified healthcare professionals who are experienced in the management of glioma.

SKU: TEST-4682 Category:

Related products